Important pharmacy news and late-breaking industry information updated daily.

FDA on Friday gave final approval of the first generic naloxone hydrochloride nasal spray (Teva Pharmaceuticals USA). The agency gave tentative approval to this generic drug product in June 2018.

NIH is launching a more than $350 million study that aims to substantially reduce opioid overdose deaths in four states hit hard by the opioid crisis.

Penicillin allergy skin testing (PAST) is rapidly becoming an effective, long-term antimicrobial stewardship tool to optimize antimicrobial prescribing in various practice settings. In February 2019, a group of pharmacists from various institutions across the United States published a practical guide to implementing a PAST program. “Pharmacists are well positioned to offer PAST services given their existing duties as part of the health care team and expertise and training with drug allergy issues,” the authors wrote.

Federal officials announced Wednesday enforcement actions against 60 individuals, including 53 medical professionals, for their alleged participation in the illegal prescribing and distributing of opioids and other dangerous narcotics.

As part of its ongoing efforts to protect consumers from potentially unlawful dietary supplements, FDA said Tuesday it is launching a new tool to quickly alert the public to when it becomes aware of ingredients that appear to be unlawfully marketed in dietary supplements.

The number of confirmed measles cases in the United States increased sharply in the past week, with 90 new cases as of April 11. CDC said Monday there have been 555 cases of the highly infectious disease recorded so far in 2019.

FDA on Friday granted accelerated approval to erdafitinib (Balversa—Janssen Pharmaceutical) for the treatment of adults with locally advanced or metastatic bladder cancer that has an FGFR3 or FGFR2 genetic alteration and that has progressed during or following prior platinum-containing chemotherapy.

FDA issued a final rule on April 11 that would ban certain harmful active ingredients in OTC hand sanitizers. The regulation finalized a previous determination from FDA that 28 active ingredients, including triclosan and benzethonium chloride, are not allowed in these products.

Rite Aid reports it will start selling CBD creams, lotions, and lip balms in Washington and Oregon this month, testing public demand for cannabis-based consumer products. Walgreens and CVS also recently introduced similar products in some of their stores.

Despite the lay perception of propofol in the wake of Michael Jackson’s death, it has been shown to be safe and effective when used by appropriately trained providers, according to many high-quality published studies.